House Commerce Health Subcommittee Generics Hearing Planned For June
This article was originally published in The Tan Sheet
Executive Summary
The House Energy & Commerce Committee/Health Subcommittee intends to hold a hearing on generic drug issues in June.
You may also be interested in...
McCain/Schumer Generic Drug Bill Would End 30-Month Stay Of Approval
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
Pediatric Study Incentive Could Be Tax Credit, Not Exclusivity - Rep. Pallone
Tax credits or reimbursements may be alternative incentives to encourage manufacturers to conduct pediatric studies, Rep. Frank Pallone (D-N.J.) suggested during a House Energy & Commerce/Health Subcommittee hearing May 3.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC